<DOC>
	<DOCNO>NCT01772277</DOCNO>
	<brief_summary>To assess efficacy safety local application intraoperative mitomycin C ( MMC ) osteotomy site endoscopic dacryocystorhinostomy ( EN-DCR ) .</brief_summary>
	<brief_title>Efficacy Mitomycin C Endoscopic Dacryocystorhinostomy : A Systematic Review Meta-Analysis</brief_title>
	<detailed_description>Mitomycin C ( MMC ) antineoplastic agent inhibits synthesis DNA , cellular RNA , protein inhibit synthesis collagen fibroblast . MMC originally use systemic chemotherapeutic agent , widely use ophthalmic practice intraoperatively postoperatively prevention pterygium recurrence , enhance success rate glaucoma filtration surgery . Recently , use MMC describe lacrimal drainage surgery . It postulate adjunctive use MMC osteotomy site endoscopic dacryocystorhinostomy ( EN-DCR ) surgery could inhibit scar granulation tissue formation around osteotomy site common canaliculus enhance success EN-DCR surgery . Many control trial investigate adjunctive MMC primary revision EN-DCR augment surgical success rate , result completely consistent . To best knowledge , meta-analysis comparison success rate EN-DCR MMC ( MMC group ) endoscopic dacryocystorhinostomy without MMC ( control group ) . Therefore , aim study undertake systematic review meta-analysis evaluate efficacy intraoperative MMC application EN-DCR surgery help ophthalmologists determine whether useful adjuvant EN-DCR surgery .</detailed_description>
	<mesh_term>Dacryocystitis</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>1. comparative study ; 2. adult patient ( &gt; 18 year ) NLDO undergo primary revision ENDCR ; 3. study include require provide success rate MMC control group , follow time 6 month . 1. study provide success rate ; 2. study include pediatric case .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Endoscopic dacryocystorhinostomy</keyword>
	<keyword>Mitomycin C</keyword>
</DOC>